Countries around the world have legalized cannabis. Could psychedelics be next?

Countries around the world have legalized cannabis. Could psychedelics be next? Global sales of antidepressant drugs are expected to exceed $20 billion by 2030. Now, some investors are betting that psychedelic therapies can grab a share of that enormous market. Due to their mind-bending qualities, substances like psilocybin, ketamine, LSD and MDMA remain illegal in most of the world. That may help explain why markets are showing strong doubts about the industry. A CNBC examination of seven psychedelic stocks that trade in the United States found that most of them are close to their 52-week lows as of mid-February, with some more than 80% lower than their 52-week highs. But venture firms that invest in the new industry are standing by the drugs. Watch the full report: https://youtu.be/A8SSpMAY5P4 #CNBC #Shorts ----- Subscribe: http://cnb.cx/2wuoARM CNBC International TV: https://cnb.cx/2NGytpz Facebook: https://www.facebook.com/cnbcinternational Instagram: https://www.instagram.com/cnbcinternational/ Twitter: https://twitter.com/CNBCi